Elevation of serum pyruvate kinase M2 (PKM2) in IBD and its relationship to IBD indices

Our data suggests PKM2 as a putative biomarker for IBD and the dysbiosis of microflora in CD. Investigations involving larger number of clinical patients are necessary to validate its use as a serum biomarker of IBD.